thiophenes has been researched along with Focal Segmental Glomerulosclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, JSD; Chang, SY; Chenier, I; El-Mortada, MA; Ingelfinger, JR; Liao, MC; Lo, CS; Miyata, KN; Peng, J; Yamashita, M; Zhang, SL; Zhao, XP | 1 |
| Kossmehl, P; Kreutz, R; Neumayer, HH; Paul, M; Rothermund, L | 1 |
| Brooks, DP; Gandhi, M; Meyer, TW | 1 |
3 other study(ies) available for thiophenes and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
Topics: Angiotensin II; Animals; Cathepsin L; Glomerulosclerosis, Focal Segmental; Imidazoles; Kidney Diseases; Male; Mice; Mice, Knockout; Podocytes; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes | 2022 |
Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension.
Topics: Acrylates; Animals; Antihypertensive Agents; Aspartic Acid Endopeptidases; Blood Pressure; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Glomerulosclerosis, Focal Segmental; Hypertension, Renal; Imidazoles; Kidney; Male; Metalloendopeptidases; Models, Cardiovascular; Nephritis, Interstitial; Organ Size; Osteopontin; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Renin; Renin-Angiotensin System; RNA, Messenger; Sialoglycoproteins; Systole; Thiophenes | 2003 |
Effects of eprosartan on glomerular injury in rats with reduced renal mass.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Drug Evaluation, Preclinical; Glomerulosclerosis, Focal Segmental; Imidazoles; Male; Nephrectomy; Proteinuria; Rats; Thiophenes; Vasoconstrictor Agents | 1999 |